Liberia to get experimental Ebola drug to treat two doctors

By REUTERS
August 12, 2014 10:56

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again



DAKAR - Liberia will receive enough of an experimental Ebola drug to treat just two infected Liberian doctors, Information Minister Lewis Brown said, after the US Food and Drug Administration (FDA) approved its export.



Brown said Liberia's Health Ministry had contacted the US manufacturer of ZMapp, Mapp Biopharmaceutical, and asked the FDA to quickly approve its export.

The doctors had consented in writing to the treatment, the minister said.

Related Content

Breaking news
July 19, 2018
Hundreds protest surrogacy law in Tel Aviv

By JERUSALEM POST STAFF